RECCHIA, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 7.103
EU - Europa 3.419
AS - Asia 1.144
OC - Oceania 49
AF - Africa 12
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.740
Nazione #
US - Stati Uniti d'America 7.034
IT - Italia 1.084
GB - Regno Unito 947
SE - Svezia 459
CN - Cina 422
SG - Singapore 315
DE - Germania 281
HK - Hong Kong 170
UA - Ucraina 140
FR - Francia 133
FI - Finlandia 103
TR - Turchia 91
BG - Bulgaria 60
BE - Belgio 46
AU - Australia 39
NL - Olanda 37
CA - Canada 34
BZ - Belize 28
ID - Indonesia 27
LT - Lituania 27
VN - Vietnam 25
JP - Giappone 24
IE - Irlanda 19
IR - Iran 19
IN - India 16
CZ - Repubblica Ceca 14
CH - Svizzera 13
AT - Austria 10
KR - Corea 10
NZ - Nuova Zelanda 10
ES - Italia 9
MY - Malesia 9
ZA - Sudafrica 9
RU - Federazione Russa 7
SI - Slovenia 7
MX - Messico 6
RO - Romania 6
GR - Grecia 4
PK - Pakistan 4
PT - Portogallo 4
BR - Brasile 3
EU - Europa 3
TH - Thailandia 3
TW - Taiwan 3
AL - Albania 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
LB - Libano 2
NO - Norvegia 2
UY - Uruguay 2
BD - Bangladesh 1
DK - Danimarca 1
HR - Croazia 1
IL - Israele 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 11.740
Città #
Fairfield 1.040
Southend 746
Chandler 598
Woodbridge 586
Houston 490
Ashburn 478
Seattle 377
Santa Clara 363
Cambridge 360
Ann Arbor 336
Wilmington 307
Jacksonville 299
Dearborn 278
Nyköping 274
Singapore 246
Modena 194
Hong Kong 160
Beijing 108
San Diego 95
Bologna 91
Princeton 71
Helsinki 61
San Jose 59
Sofia 59
Bremen 55
Eugene 52
New York 50
Izmir 45
Brussels 44
Shanghai 34
Milan 32
Redwood City 32
London 31
Los Angeles 31
Rome 30
Des Moines 29
Falls Church 29
Belize City 28
Jakarta 27
Dong Ket 25
Paris 21
Bari 20
Buffalo 19
Munich 19
Boardman 18
Hefei 18
Parma 18
Phoenix 17
Las Vegas 16
Chicago 14
San Francisco 14
Dublin 13
Fremont 13
Toronto 13
Albuquerque 12
Brno 12
Camden 12
Saint Louis 12
Frankfurt am Main 11
Nanjing 11
Norwalk 11
Wuhan 11
Napoli 10
Valsamoggia 10
Adelaide 9
Canberra 9
Kinde 9
Minerbio 9
San Giuliano Milanese 9
Auckland 8
Castelfranco Emilia 8
Kilburn 8
Medesano 8
Porretta Terme 8
Soave 8
Trento 8
Vienna 8
Columbus 7
Goito 7
Jinan 7
Ottawa 7
Padova 7
Zhengzhou 7
Amstelveen 6
Ankara 6
Dallas 6
Hounslow 6
Mountain View 6
Reggio Emilia 6
Reggio Nell'emilia 6
Turin 6
Vicenza 6
Amsterdam 5
Empoli 5
Forlì 5
Grafing 5
Gunzenhausen 5
Kunming 5
Melbourne 5
Montereale Valcellina 5
Totale 8.840
Nome #
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 428
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 301
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 296
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 271
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 269
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 268
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 264
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 261
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 260
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 259
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 258
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 257
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 240
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 232
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 219
Long-Term Skin Regeneration From a Gene-Targeted Human Epidermal Stem Cell Clone 219
Nuclear architecture dictates HIV-1 integration site selection 215
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 211
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 211
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 207
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy 207
Tracking gene-modified T cells in vivo. 206
A single epidermal stem cell strategy for safe ex vivo gene therapy 194
AAV-CRISPR Persistence in the Eye of the Beholder 193
Site-specific integration into the human genome: Ready for clinical application? 187
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 187
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 185
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 185
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 184
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 181
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 176
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 173
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 172
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 172
Defining the lentiviral integrome in human hematopoietic cells 172
Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration 170
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. 162
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells 161
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 160
Comprehensive genomic access to vector integration in clinical gene therapy. 155
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector 154
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 150
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 143
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 143
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 143
Transcriptional and epigenetic analyses of the DMD locus reveal novel cisâ acting DNA elements that govern muscle dystrophin expression 140
Site-specific integration by the adeno-associated virus rep protein 139
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 139
Targeted integration of a large transgene cassette by TALEN and ZFN-mediated homologous recombination. 138
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 133
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector 130
Gene editing prospects for treating inherited retinal diseases 126
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 126
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 124
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 123
Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination 122
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 109
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 102
The Journal of Gene Medicine European Society of Gene Therapy Young Investigator Award 2004 93
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 74
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 72
Corrigendum to: “Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression”. [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138–1147.] (Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2017) 1860(11) (1138–1147), (S1874939917301359), (10.1016/j.bbagrm.2017.08.010)) 69
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 63
Collagen VII gene delivery via an Adeno-Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 61
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 60
TALEN-mediated in situ correction of a genetic defect by homologous recombination into the native locus 57
Engineered nucleases-mediated in situ correction of a genetic defect by homologous recombination into the native locus 57
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 56
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 47
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 44
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 38
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 35
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 33
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 32
Totale 12.003
Categoria #
all - tutte 50.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.735 0 0 0 0 266 345 382 250 199 88 136 69
2020/20212.067 231 53 155 179 129 232 170 202 97 288 217 114
2021/20221.756 77 173 208 102 113 101 132 123 145 112 279 191
2022/20231.921 211 207 165 218 243 257 50 160 207 25 96 82
2023/20241.186 53 72 93 99 217 70 113 147 28 84 83 127
2024/2025928 105 46 131 229 417 0 0 0 0 0 0 0
Totale 12.003